Cargando…
Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022
Patients with multidrug-resistant tuberculosis (MDR-TB) who have comorbidities, complications, and experience serious adverse events (SAEs) are at substantial risk of having unfavorable hospital outcomes. We assessed characteristics and discharge outcomes of 138 MDR-TB patients hospitalized in the N...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384159/ https://www.ncbi.nlm.nih.gov/pubmed/37505634 http://dx.doi.org/10.3390/tropicalmed8070338 |
_version_ | 1785081088767426560 |
---|---|
author | Alumkulova, Gulzat Hazoyan, Anna Zhdanova, Elena Kuznetsova, Yuliia Tripathy, Jaya Prasad Sargsyan, Aelita Goncharova, Olga Kadyrov, Meder Istamov, Kylychbek Ortuño-Gutiérrez, Nimer |
author_facet | Alumkulova, Gulzat Hazoyan, Anna Zhdanova, Elena Kuznetsova, Yuliia Tripathy, Jaya Prasad Sargsyan, Aelita Goncharova, Olga Kadyrov, Meder Istamov, Kylychbek Ortuño-Gutiérrez, Nimer |
author_sort | Alumkulova, Gulzat |
collection | PubMed |
description | Patients with multidrug-resistant tuberculosis (MDR-TB) who have comorbidities, complications, and experience serious adverse events (SAEs) are at substantial risk of having unfavorable hospital outcomes. We assessed characteristics and discharge outcomes of 138 MDR-TB patients hospitalized in the National Referral Center of Bishkek, Kyrgyz Republic, from January 2020 to August 2022. The main clinical characteristics included pulmonary complications (23%), malnutrition (33%), severe anemia (17%), diabetes mellitus (13%), viral hepatitis B and C (5%), and HIV infection (3%). Of those patients, 95% were successfully managed and discharged from hospital. Seven patients had unfavorable discharge outcomes (three patients died and four had a worsened clinical condition). Comorbidities (diabetes, and/or HIV), severe anemia, pulmonary complications, cardiovascular disorders, alcohol abuse, and SAEs were associated with unfavorable discharge outcomes. Sixty-five percent of the patients had SAEs, with electrolyte imbalance (25%), gastrointestinal disease (18%), hepatotoxicity (16%), and anemia (14%) being the most frequent. Successful resolution occurred in 91% of patients with SAEs. In summary, our study documented that sick patients who were hospitalized with MDR-TB were well managed and had good hospital discharge outcomes, despite the fact that they had comorbidities, complications, and SAEs. This information should assist in the referral and management of such patients in the future. |
format | Online Article Text |
id | pubmed-10384159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103841592023-07-30 Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 Alumkulova, Gulzat Hazoyan, Anna Zhdanova, Elena Kuznetsova, Yuliia Tripathy, Jaya Prasad Sargsyan, Aelita Goncharova, Olga Kadyrov, Meder Istamov, Kylychbek Ortuño-Gutiérrez, Nimer Trop Med Infect Dis Article Patients with multidrug-resistant tuberculosis (MDR-TB) who have comorbidities, complications, and experience serious adverse events (SAEs) are at substantial risk of having unfavorable hospital outcomes. We assessed characteristics and discharge outcomes of 138 MDR-TB patients hospitalized in the National Referral Center of Bishkek, Kyrgyz Republic, from January 2020 to August 2022. The main clinical characteristics included pulmonary complications (23%), malnutrition (33%), severe anemia (17%), diabetes mellitus (13%), viral hepatitis B and C (5%), and HIV infection (3%). Of those patients, 95% were successfully managed and discharged from hospital. Seven patients had unfavorable discharge outcomes (three patients died and four had a worsened clinical condition). Comorbidities (diabetes, and/or HIV), severe anemia, pulmonary complications, cardiovascular disorders, alcohol abuse, and SAEs were associated with unfavorable discharge outcomes. Sixty-five percent of the patients had SAEs, with electrolyte imbalance (25%), gastrointestinal disease (18%), hepatotoxicity (16%), and anemia (14%) being the most frequent. Successful resolution occurred in 91% of patients with SAEs. In summary, our study documented that sick patients who were hospitalized with MDR-TB were well managed and had good hospital discharge outcomes, despite the fact that they had comorbidities, complications, and SAEs. This information should assist in the referral and management of such patients in the future. MDPI 2023-06-25 /pmc/articles/PMC10384159/ /pubmed/37505634 http://dx.doi.org/10.3390/tropicalmed8070338 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alumkulova, Gulzat Hazoyan, Anna Zhdanova, Elena Kuznetsova, Yuliia Tripathy, Jaya Prasad Sargsyan, Aelita Goncharova, Olga Kadyrov, Meder Istamov, Kylychbek Ortuño-Gutiérrez, Nimer Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 |
title | Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 |
title_full | Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 |
title_fullStr | Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 |
title_full_unstemmed | Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 |
title_short | Discharge Outcomes of Severely Sick Patients Hospitalized with Multidrug-Resistant Tuberculosis, Comorbidities, and Serious Adverse Events in Kyrgyz Republic, 2020–2022 |
title_sort | discharge outcomes of severely sick patients hospitalized with multidrug-resistant tuberculosis, comorbidities, and serious adverse events in kyrgyz republic, 2020–2022 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384159/ https://www.ncbi.nlm.nih.gov/pubmed/37505634 http://dx.doi.org/10.3390/tropicalmed8070338 |
work_keys_str_mv | AT alumkulovagulzat dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT hazoyananna dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT zhdanovaelena dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT kuznetsovayuliia dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT tripathyjayaprasad dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT sargsyanaelita dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT goncharovaolga dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT kadyrovmeder dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT istamovkylychbek dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 AT ortunogutierreznimer dischargeoutcomesofseverelysickpatientshospitalizedwithmultidrugresistanttuberculosiscomorbiditiesandseriousadverseeventsinkyrgyzrepublic20202022 |